P
About
Co-founder, CEO and President of Neurimmune. Key opinion leader in neurodegenerative diseases. Pioneer in therapeutic approaches for neurodegenerative diseases; inventor and developer of aducanumab in partnership with Biogen, first disease-modifying treatment and first approved therapy in over two decades for Alzheimer disease. Professor emeritus at Institute for Regenerative Medicine, University of Zurich. Potamkin prize winner; member of German Academy of Sciences. MD from University of Heidelberg.
Focus Areas
Diagnostics, Biopharma, Biotech, Life Sciences
Location
๐ Based in Zurich, Switzerland
Verified Contact & Outreach Agent
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...